WallStreetZenWallStreetZen

NYSEMKT: ARMP
Armata Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

Analyst price target for ARMP

Based on 1 analyst offering 12 month price targets for Armata Pharmaceuticals Inc.
Min Forecast
$7.00+162.66%
Avg Forecast
$7.00+162.66%
Max Forecast
$7.00+162.66%

Should I buy or sell ARMP stock?

Based on 1 analyst offering ratings for Armata Pharmaceuticals Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ARMP stock forecasts and price targets.

ARMP stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-22

1 of 1

ARMP vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ARMP$2.67$7.00+162.66%Buy
RNAC$17.91$51.00+184.76%Buy
PDSB$2.65$17.33+555.31%Strong Buy
IOBT$1.48$8.00+440.54%Buy
BRNS$2.51$8.00+218.73%Buy

Armata Pharmaceuticals Stock Forecast FAQ

Is Armata Pharmaceuticals Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NYSEMKT: ARMP) stock is to Buy ARMP stock.

Out of 1 analyst, 0 (0%) are recommending ARMP as a Strong Buy, 1 (100%) are recommending ARMP as a Buy, 0 (0%) are recommending ARMP as a Hold, 0 (0%) are recommending ARMP as a Sell, and 0 (0%) are recommending ARMP as a Strong Sell.

If you're new to stock investing, here's how to buy Armata Pharmaceuticals stock.

What is ARMP's Price Target?

According to 1 Wall Street analyst that have issued a 1 year ARMP price target, the average ARMP price target is $7.00, with the highest ARMP stock price forecast at $7.00 and the lowest ARMP stock price forecast at $7.00.

The Wall Street analyst predicted that Armata Pharmaceuticals's share price could reach $7.00 by Mar 22, 2025. The average Armata Pharmaceuticals stock price prediction forecasts a potential upside of 162.66% from the current ARMP share price of $2.67.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.